Afuco™ Anti-Human FGF19 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-FGF19 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-FGF19 antibodies provide important therapeutic and diagnostic agents for use in targeting pathological conditions associated with expression and/or activity of the FGF19-FGFR4 pathways.
Supplier Creative Biolabs
Product # AFC-265CL
Pricing Inquiry
Host Mouse
Target FGF19
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4 °C, -20°C if preferred
Feedback